Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Schenkel, L
The first medication that targets neurotransmitter systems other than dopamine has been approved for use
After six months, theyll be checked for improvements in metrics such as pain level, mood, sleep patterns, cholesterol, and blood sugar
Incretin-based drugs and the incidence of endometrial cancer among people with type 2 diabetes: active comparator new-user design
Following iFSP1 treatment, the sensitivity of tumor cells to ferroptosis was obviously enhanced, suggesting a new strategy for tumor treatment
US$ 20.40
US$ 21.64
US$ 21.46
US$ 24.38
US$ 29.29
